GP
NVO

Guardian Partners’s Novo Nordisk NVO Stock Holding History

Guardian Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Sell
65,512
-9,028
-12% -$428K 0.2% 82
2025
Q4 		$3.51M Sell
74,540
-59,823
-45% -$3.06M 0.28% 74
2025
Q3 		$7.95M Buy
134,363
+3,811
+3% +$223K 0.67% 53
2025
Q2 		$9.1M Buy
130,552
+1,814
+1% +$123K 0.82% 37
2025
Q1 		$7.89M Buy
128,738
+1,347
+1% +$111K 0.82% 41
2024
Q4 		$10.9M Buy
+127,391
New +$13.8M 1.11% 30

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Guardian Partners's NVO Position: Q1 2026 in Review

Guardian Partners reduced its Novo Nordisk (NVO) stake by 12% in Q1 2026, selling an estimated $428K and leaving 65,512 shares worth $2.41M. The position accounts for 0.2% of the portfolio, ranked #82.

Guardian Partners first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.9M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Guardian Partners held 65,512 shares of Novo Nordisk worth $2.41M as of Q1 2026.
  • Guardian Partners sold 9,028 Novo Nordisk shares in Q1 2026, an estimated $428K.
  • Novo Nordisk made up 0.2% of Guardian Partners's portfolio in Q1 2026, its #82 holding.
  • Guardian Partners first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • Guardian Partners's Novo Nordisk position peaked at $10.9M in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Guardian Partners's 13F filing for Q1 2026, filed 18 May 2026.